Antibody–Drug Conjugates in Lung Cancer: Promise, Progress, and Persistent Challenges

Panagiotis Paliogiannis, Giorgia Fara, Angelo Zinellu, Alessandro Giuseppe Fois, Giuseppe Palmieri

Open source

DOI
10.3390/cimb48090868
Published
2026-08-26
Container
Current Issues in Molecular Biology
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cimb48090868,
  title = {Antibody–Drug Conjugates in Lung Cancer: Promise, Progress, and Persistent Challenges},
  author = {Panagiotis Paliogiannis and Giorgia Fara and Angelo Zinellu and Alessandro Giuseppe Fois and Giuseppe Palmieri},
  year = {2026},
  journal = {Current Issues in Molecular Biology},
  doi = {10.3390/cimb48090868},
  url = {https://doi.org/10.3390/cimb48090868}
}

RIS

TY  - JOUR
TI  - Antibody–Drug Conjugates in Lung Cancer: Promise, Progress, and Persistent Challenges
AU  - Panagiotis Paliogiannis
AU  - Giorgia Fara
AU  - Angelo Zinellu
AU  - Alessandro Giuseppe Fois
AU  - Giuseppe Palmieri
PY  - 2026
JO  - Current Issues in Molecular Biology
DO  - 10.3390/cimb48090868
UR  - https://doi.org/10.3390/cimb48090868
ER  - 

APA

Paliogiannis, P., Fara, G., Zinellu, A., Fois, A. G., & Palmieri, G. (2026). Antibody–Drug Conjugates in Lung Cancer: Promise, Progress, and Persistent Challenges. Current Issues in Molecular Biology. https://doi.org/10.3390/cimb48090868

Source records